Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Cell cycle arrest in Batten disease lymphoblast cells.

Kang S, Kim JB, Heo TH, Kim SJ.

Gene. 2013 May 1;519(2):245-50. doi: 10.1016/j.gene.2013.02.022. Epub 2013 Feb 28.

PMID:
23458879
[PubMed - indexed for MEDLINE]
2.

Altered levels of α-synuclein and sphingolipids in Batten disease lymphoblast cells.

Kang S, Heo TH, Kim SJ.

Gene. 2014 Apr 15;539(2):181-5. doi: 10.1016/j.gene.2014.02.017. Epub 2014 Feb 15.

PMID:
24534465
[PubMed - indexed for MEDLINE]
3.

Defective lysosomal arginine transport in juvenile Batten disease.

Ramirez-Montealegre D, Pearce DA.

Hum Mol Genet. 2005 Dec 1;14(23):3759-73. Epub 2005 Oct 26.

PMID:
16251196
[PubMed - indexed for MEDLINE]
Free Article
4.

Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.

Chan CH, Mitchison HM, Pearce DA.

Hum Mol Genet. 2008 Nov 1;17(21):3332-9. doi: 10.1093/hmg/ddn228. Epub 2008 Aug 4.

PMID:
18678598
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

CLN3p impacts galactosylceramide transport, raft morphology, and lipid content.

Rusyn E, Mousallem T, Persaud-Sawin DA, Miller S, Boustany RM.

Pediatr Res. 2008 Jun;63(6):625-31. doi: 10.1203/PDR.0b013e31816fdc17.

PMID:
18317235
[PubMed - indexed for MEDLINE]
6.

Altered gene expression in the eye of a mouse model for batten disease.

Chattopadhyay S, Kingsley E, Serour A, Curran TM, Brooks AI, Pearce DA.

Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2893-905.

PMID:
15326100
[PubMed - indexed for MEDLINE]
Free Article
7.

CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide.

Puranam KL, Guo WX, Qian WH, Nikbakht K, Boustany RM.

Mol Genet Metab. 1999 Apr;66(4):294-308.

PMID:
10191118
[PubMed - indexed for MEDLINE]
8.

Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).

Leman AR, Pearce DA, Rothberg PG.

Hum Genet. 2005 May;116(6):544. No abstract available.

PMID:
15991331
[PubMed - indexed for MEDLINE]
9.

Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).

Leman AR, Pearce DA, Rothberg PG.

Hum Genet. 2005 Feb;116(3):236. No abstract available.

PMID:
15818814
[PubMed - indexed for MEDLINE]
10.

Loss of the Batten disease gene CLN3 prevents exit from the TGN of the mannose 6-phosphate receptor.

Metcalf DJ, Calvi AA, Seaman MNj, Mitchison HM, Cutler DF.

Traffic. 2008 Nov;9(11):1905-14. doi: 10.1111/j.1600-0854.2008.00807.x. Epub 2008 Aug 4.

PMID:
18817525
[PubMed - indexed for MEDLINE]
11.

Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).

Seigel GM, Lotery A, Kummer A, Bernard DJ, Greene ND, Turmaine M, Derksen T, Nussbaum RL, Davidson B, Wagner J, Mitchison HM.

Mol Cell Neurosci. 2002 Apr;19(4):515-27.

PMID:
11988019
[PubMed - indexed for MEDLINE]
12.

Amlodipine prevents apoptotic cell death by correction of elevated intracellular calcium in a primary neuronal model of Batten disease (CLN3 disease).

Warnock A, Tan L, Li C, An Haack K, Narayan SB, Bennett MJ.

Biochem Biophys Res Commun. 2013 Jul 12;436(4):645-9. doi: 10.1016/j.bbrc.2013.04.113. Epub 2013 Jun 13.

PMID:
23769828
[PubMed - indexed for MEDLINE]
13.

Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis.

Weimer JM, Benedict JW, Getty AL, Pontikis CC, Lim MJ, Cooper JD, Pearce DA.

Brain Res. 2009 Apr 17;1266:93-107. doi: 10.1016/j.brainres.2009.02.009. Epub 2009 Feb 20.

PMID:
19230832
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Altered flurothyl seizure induction latency, phenotype, and subsequent mortality in a mouse model of juvenile neuronal ceroid lipofuscinosis/batten disease.

Kriscenski-Perry E, Applegate CD, Serour A, Mhyre TR, Leonardo CC, Pearce DA.

Epilepsia. 2002 Oct;43(10):1137-40.

PMID:
12366726
[PubMed - indexed for MEDLINE]
15.

Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease.

Kovács AD, Weimer JM, Pearce DA.

Neurobiol Dis. 2006 Jun;22(3):575-85. Epub 2006 Feb 17.

PMID:
16483786
[PubMed - indexed for MEDLINE]
16.

CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.

Narayan SB, Pastor JV, Mitchison HM, Bennett MJ.

Brain. 2004 Aug;127(Pt 8):1748-54. Epub 2004 Jul 7.

PMID:
15240430
[PubMed - indexed for MEDLINE]
Free Article
17.

N-acetylcysteine normalizes the urea cycle and DNA repair in cells from patients with Batten disease.

Kim JB, Lim N, Kim SJ, Heo TH.

Cell Biochem Funct. 2012 Dec;30(8):677-82. doi: 10.1002/cbf.2849. Epub 2012 Jun 13.

PMID:
22692827
[PubMed - indexed for MEDLINE]
18.

Investigation of Batten disease with the yeast Saccharomyces cerevisiae.

Pearce DA, Sherman F.

Mol Genet Metab. 1999 Apr;66(4):314-9.

PMID:
10191120
[PubMed - indexed for MEDLINE]
19.

Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.

Mantel I, Brantley MA Jr, Bellmann C, Robson AG, Holder GE, Taylor A, Anderson G, Moore AT.

Klin Monbl Augenheilkd. 2004 May;221(5):427-30.

PMID:
15162299
[PubMed - indexed for MEDLINE]
20.

A model for Batten disease protein CLN3: functional implications from homology and mutations.

Janes RW, Munroe PB, Mitchison HM, Gardiner RM, Mole SE, Wallace BA.

FEBS Lett. 1996 Dec 9;399(1-2):75-7.

PMID:
8980123
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk